Effect of Oat Beta Glucan in Managing Blood Pressure

Status Completed

Clinical Trial Summary

This is a randomized, double-blinded, cross-over pilot study comparing the effects of ingesting oats containing high molecular weight β-glucan in reducing blood pressure.

Clinical Trial Description

The pilot study will consist of 2 study periods: one treatment period and one control period. The treatment period will provide food products made from oats containing a total of 4 grams per day high molecular weight (HMW) oat β-glucan, whereas, the control period will provide food products made primarily from wheat with no β-glucan. The study will be located at the Chronic Disease Innovation Centre in Seven Oaks General Hospital, Winnipeg, Canada. The primary objective of this study is to investigate the effect of ingestion of HMW oat β-glucan on ambulatory blood pressure. Participants will be asked to wear an ambulatory blood pressure monitor for 24 hours per day for 3 consecutive days at the beginning and end of each treatment period. This device automatically measures blood pressure every 15-30 minutes during the day and 30 to 60 minutes during the evening. The study has been designed to be conducted virtually. Participants will consent to receive both treatment and control over two 4-week periods online. The participants will be randomized to different orders of treatment, with a 4 week wash out period in between. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05029427
Study type	Interventional
Source	University of Manitoba
Contact
Status	Completed
Phase	N/A
Start date	November 28, 2021
Completion date	December 23, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03626363` - Mindfulness and Neural Cardiovascular Control in Humans	N/A
Recruiting	`NCT05121337` - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension	N/A
Active, not recruiting	`NCT05062161` - Sleep Duration and Blood Pressure During Sleep	N/A
Completed	`NCT04953650` - Intermittent Fasting Towards Elevated Blood Pressure	N/A
Enrolling by invitation	`NCT06033417` - Walking and Blood Pressure in Older Adults With Respiratory Impairment.	N/A
Completed	`NCT03716960` - The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women.	N/A
Completed	`NCT05533268` - Effect of Mental and Physical Training on Blood Pressure	N/A
Recruiting	`NCT05370625` - To Assess TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure	N/A
Not yet recruiting	`NCT06376812` - No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women	N/A
Not yet recruiting	`NCT06348225` - Post-exercise Hot Water Immersion to Improve Overnight Blood Pressure	N/A
Recruiting	`NCT04766424` - Sleep Technology Intervention to Target Cardiometabolic Health	N/A
Recruiting	`NCT05297708` - Office, Home, and Ambulatory Blood Pressure
Completed	`NCT00869193` - Effect of Grape Seed Extract on Blood Pressure	N/A
Completed	`NCT04298944` - Association of Mood With Risk for Atherosclerosis
Recruiting	`NCT05397535` - Baduanjin Lower Elevated Blood PreSsure Study	N/A
Completed	`NCT05928676` - Open Label Clinical Trial of Vascanox® HP on Nitric Oxide and Blood Pressure	N/A
Not yet recruiting	`NCT03764020` - Trial of Oral Melatonin in Elevated Blood Pressure	Phase 3
Suspended	`NCT03508739` - Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition	Phase 3
Active, not recruiting	`NCT05469503` - Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure	N/A
Recruiting	`NCT05955040` - Treatment of Elevated Blood Pressures in Early Pregnancy	Phase 2